Hyperthermic Intraperitoneal Chemotherapy: Moving Toward Improved Outcomes
The diagnosis of peritoneal carcinomatosisis can be devastating, but a combination of cytoreductive surgical resection and hyperthermic intraperitoneal chemotherapy has the potential to provide some patients with long-term survival.
Orca-T Provides Post-HCT Survival Benefits vs PTCy in Blood Cancers
Immune Engager Therapies Improve Responses, PFS in RRMM After CAR T-Cell Therapy
Liso-Cel Elicits Rapid, Durable Responses in Relapsed/Refractory CLL/SLL
Adding Azoles May Not Impact Efficacy of Ruxolitinib in Acute GVHD Treatment
2 Commerce Drive Cranbury, NJ 08512